background
background
EWTX
Edgewise Therapeutics Inc
$14.58
+0.13
+0.90%
Earnings Expectation?
Beat
Meet
Miss
Expected Price Action?
Up
Flat
Down
Thursday
August 7, 2025
8:00 AM ET
Edgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Thursday
May 8, 2025
8:00 AM ET
Edgewise Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
Wednesday
March 26, 2025
4:45 PM ET
Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Results from Phase 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Eastern Time
Monday
March 3, 2025
8:00 AM ET
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights